Technical Analysis for BIAF - bioAffinity Technologies, Inc.

Grade Last Price % Change Price Change
C 1.66 -7.78% -0.14
BIAF closed up 26.75 percent on Friday, February 23, 2024, on 15.77 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Bullish Engulfing Bullish -7.77%
Crossed Above 20 DMA Bullish -7.77%
Crossed Above 200 DMA Bullish -7.77%
Crossed Above 50 DMA Bullish -7.77%
MACD Bullish Centerline Cross Bullish -7.77%
MACD Bullish Signal Line Cross Bullish -7.77%
Stochastic Buy Signal Bullish -7.77%
Expansion Breakout Bullish Swing Setup -7.77%
Expansion Pivot Buy Setup Bullish Swing Setup -7.77%
Pocket Pivot Bullish Swing Setup -7.77%

   Recent Intraday Alerts

Alert Time
2x Volume Pace 35 minutes ago
1.5x Volume Pace 35 minutes ago
3x Volume Pace 35 minutes ago
Down 5% 35 minutes ago
Down 3% 35 minutes ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Lung Cancer Molecular Diagnostics Cancer Therapeutics

Is BIAF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.24
52 Week Low 0.9548
Average Volume 20,061
200-Day Moving Average 1.61
50-Day Moving Average 1.54
20-Day Moving Average 1.56
10-Day Moving Average 1.54
Average True Range 0.12
RSI (14) 66.67
ADX 19.88
+DI 42.39
-DI 11.45
Chandelier Exit (Long, 3 ATRs) 1.79
Chandelier Exit (Short, 3 ATRs) 1.77
Upper Bollinger Bands 1.71
Lower Bollinger Band 1.41
Percent B (%b) 1.32
BandWidth 18.84
MACD Line 0.01
MACD Signal Line 0.00
MACD Histogram 0.0075
Fundamentals Value
Market Cap 17.1 Million
Num Shares 9.5 Million
EPS -0.43
Price-to-Earnings (P/E) Ratio -4.19
Price-to-Sales 46.70
Price-to-Book 2.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.89
Resistance 3 (R3) 2.89 2.52 2.71
Resistance 2 (R2) 2.52 2.24 2.52 2.65
Resistance 1 (R1) 2.16 2.07 2.34 2.16 2.59
Pivot Point 1.79 1.79 1.88 1.79 1.79
Support 1 (S1) 1.43 1.51 1.61 1.43 1.01
Support 2 (S2) 1.06 1.34 1.06 0.95
Support 3 (S3) 0.70 1.06 0.89
Support 4 (S4) 0.70